Home › Buy Trovagene To Hedge Patent Risk In Molecular Diagnostics
 

Keywords :   


Buy Trovagene To Hedge Patent Risk In Molecular Diagnostics

2013-12-26 04:33:07| Biotech - Topix.net

Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap.

Tags: buy risk patent molecular

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11
23.11 85
23.11DANCEWITHDRAGON2 811
23.11 N5000VSE
23.11EZY POWER EDIT6
23.11RR4
23.1126.5 HG
23.11VISSLA
More »